SCHEMBL14068950

SCHEMBL14068950

CCC(CN1CCCC1)C(=O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
RAB9A P51151 3/20 0.60
MITF O75030 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
HTT P42858 2/20 0.60
ATM Q13315 2/20 0.60
GFER P55789 1/20 0.60
PAX8 Q06710 1/20 0.60
SLC6A4 P31645 2/20 0.59
LMNA P02545 5/20 0.57
HIF1A Q16665 2/20 0.57
MAPT P10636 2/20 0.57
SLC6A3 Q01959 2/20 0.52
SLC6A2 P23975 1/20 0.52
CHRM2 P08172 2/20 0.50
ADRA2B P18089 2/20 0.50
DRD3 P35462 2/20 0.50
SIGMAR1 Q99720 2/20 0.50
HRH3 Q9Y5N1 2/20 0.50
OPRD1 P41143 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29380532 0.97 ALDH1A1 (0.61) ALDH1A1RAB9AMITFSMN1; SMN2HTT
SCHEMBL18897724 0.85 SLC6A4 (0.77) ALDH1A1RAB9AMITFSMN1; SMN2HTT
SCHEMBL7718161 0.84 ALDH1A1 (0.60) ALDH1A1RAB9AMITFSMN1; SMN2HTT
Hydrochloric Acid SCHEMBL29766065 0.84 SLC6A4 (0.75) ALDH1A1RAB9AMITFSMN1; SMN2HTT
SCHEMBL6862148 0.83 ALDH1A1 (0.58) ALDH1A1RAB9AMITFSMN1; SMN2HTT
Hydrochloric Acid SCHEMBL9850462 0.82 HRH3 (0.71) ALDH1A1RAB9AMITFSMN1; SMN2HTT
SCHEMBL7713720 0.81 SLC6A4 (0.53) ALDH1A1RAB9AMITFSMN1; SMN2HTT
SCHEMBL9170851 0.81 ALDH1A1 (0.73) ALDH1A1RAB9AMITFSMN1; SMN2HTT
SCHEMBL7718745 0.81 ALDH1A1 (0.60) ALDH1A1RAB9AMITFSMN1; SMN2HTT
SCHEMBL7719239 0.81 ALDH1A1 (0.59) ALDH1A1RAB9AMITFSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234498-A1 Pyrovalerone Analogues and Therapeutic Uses Thereof PRESIDENT AND FELLOW OF HARVARD COLLEGE (US) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234498-A1 Pyrovalerone Analogues and Therapeutic Uses Thereof SLC6A2, SLC6A4, SLC6A3 ALDH1A1 1868/4885RAB9A 1515/4885MITF 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.